These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1091127)

  • 1. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man.
    Cohn K; Sakai FJ; Langston MF
    Am Heart J; 1975 May; 89(5):591-8. PubMed ID: 1091127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced rate of progression of coronary artery disease following aortocoronary saphenous vein bypass surgery.
    Pasternak R; Cohn K; Selzer A; Langston MF
    Am J Med; 1975 Feb; 58(2):166-70. PubMed ID: 1078751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.
    Br Med J; 1971 Dec; 4(5790):767-75. PubMed ID: 4943605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
    Research Committee of the Scottish Society of Physicians
    Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.
    Carlson LA; Rosenhamer G
    Acta Med Scand; 1988; 223(5):405-18. PubMed ID: 3287837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.
    Coronary Drug Project Research Group
    N Engl J Med; 1980 Oct; 303(18):1038-41. PubMed ID: 6999345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofibrate for prevention of myocardial infarction.
    Med Lett Drugs Ther; 1973 Apr; 15(9):37-8. PubMed ID: 4704699
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 9. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project.
    Coronary Drug Project Research Group
    N Engl J Med; 1977 May; 296(21):1185-90. PubMed ID: 323705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
    Graham L; Mulcahy R; Hickey N
    Atherosclerosis; 1977 Aug; 27(4):487-92. PubMed ID: 884003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
    Nikkilä EA; Viikinkoski P; Valle M; Frick MH
    Br Med J (Clin Res Ed); 1984 Jul; 289(6439):220-3. PubMed ID: 6430414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic clofibrate therapy in maintenance hemodialysis patients.
    Sherrard DJ; Goldberg AB; Haas LB; Brunzell JD
    Nephron; 1980; 25(5):219-21. PubMed ID: 7383233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol, coronaries, clofibrate and death.
    Oliver MF
    N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
    de Gennes JL
    Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186
    [No Abstract]   [Full Text] [Related]  

  • 18. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
    Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vitamin E on serum cholesterol and triglycerides in hyperlipidemic patients treated with diet and clofibrate.
    Leonhardt ET
    Am J Clin Nutr; 1978 Jan; 31(1):100-5. PubMed ID: 202160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.